Sphere Fluidics has announced it is rebranding to Sphere Bio to reflect the company’s transition from a focus on droplet-based microfluidics to a provider of integrated life sciences tools and solutions.  Founded in 2010, the company has been focused on the development of novel single-cell analysis products and R&D services for a growing portfolio of […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!